• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER; CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING Back to Search Results
Model Number 87035
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Hemorrhage/Bleeding (1888); Nerve Damage (1979); Obstruction/Occlusion (2422); Pericardial Effusion (3271); Ischemia Stroke (4418)
Event Date 01/01/2016
Event Type  Injury  
Manufacturer Narrative
Date of event: the event date is unknown.The device is not expected to be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Event Description
Aziz z, shatz d, raiman m, upadhyay ga, beaser ad, besser sa, shatz na, fu z, jiang r, nishimura t, liao h, nayak hm, tung r.Targeted ablation of ventricular tachycardia guided by wavefront discontinuities during sinus rhythm: a new functional substrate mapping strategy.Circulation.2019; 140 (17): 1383-1397.Patients with scar-related ventricular tachycardia (vt) were prospectively enrolled in the university of chicago vt ablation registry between 2016 and 2018.Isochronal late activation maps annotated to the latest local electrogram deflection were created with high-density multielectrode mapping catheters.Targeted ablation of deceleration zone (dz) (>3 isochrones within 1cm radius) was performed, prioritizing later activated regions with maximal isochronal crowding.When possible, activation mapping of vt was performed, and successful ablation sites were compared with dz locations for mechanistic correlation.Patients were prospectively followed for vt recurrence and mortality.Procedural complications were observed in 8% (n=10) of patients in the overall cohort with 1.7% (n=2) cases resulting in procedure-related mortality.One patient, with a large chronic anterior infarction with apical aneurysm and ef of 10%, underwent ablation with hemodynamic support (intra-aortic balloon pump and impella) because of vt storm in the setting of ongoing cardiogenic shock.He suffered a large femoral hematoma from venous bleeding on the first operative day in the intensive care unit requiring 4 units packed red blood cell transfusion and albumin.Systemic anticoagulation was withheld, and the patient suffered multiple embolic strokes and care was withdrawn subsequently.The other patient died from a ruptured infected pseudoaneurysm, after systemic heparinization from a chronic indwelling arterial site for balloon pump placed previously at another hospital.Three patients had complications directly related to epicardial access.An inadvertent puncture of the superior epigastric artery manifested after sheath removal and was managed with extension of subxiphoid incision site with uncomplicated stitch repair.An anterior interventricular venous bleed likely from sheath manipulation required emergent sternotomy.Both patients are alive without recurrent vt at follow-up.One patient had 2l of epicardial bleeding after rv puncture and another had rv outflow tract perforation during endocardial mapping; both were managed conservatively with a pericardial drain.A delayed pericardial effusion occurred in another case from an obstructed drain that was successfully treated with pericardiocentesis the morning after procedure.Three femoral hematomas were observed and did not require surgical intervention.Another had femoral artery occlusion after impella placement treated with emergent angioplasty and stenting with resolution.One transient phrenic nerve palsy was observed after epicardial ablation of basal lateral substrate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLAMAP ORION HIGH RESOLUTION MAPPING CATHETER
Type of Device
CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora, heredia
CS  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key11386292
MDR Text Key233809558
Report Number2134265-2021-02496
Device Sequence Number1
Product Code DRF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K143481
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 02/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number87035
Device Catalogue Number87035
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/12/2021
Initial Date FDA Received02/26/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
INTELLANAV OI
Patient Outcome(s) Death; Other; Required Intervention;
-
-